CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 843 enrolled
Drug / intervention
iodinated contrast agentsdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02766283
NCT02766283N/ACompleted

Observational Study on Hypothyroidism in Young Children Following Iodine Contrast Exposure

Bayer·observational·Posted May 9, 2016·Updated Mar 26, 2018

In Brief

An observational study evaluating iodinated contrast agents for Hypothyroidism. Completed, enrolled 843 participants across 1 site.

Detailed Summary

To investigate the incidence of detected hypothyroidism after iodinated contrast exposure in pediatric patients from birth to 3 years of age (inclusive) in a routine clinical practice setting.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHypothyroidism
CountriesIsrael
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedMay 9, 2016
Enrollment StartJun 30, 2016
Primary CompletionAug 30, 2016
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 10.1 years ago

Interventions

iodinated contrast agentsdrug

Intravascular application